精品国产乱码一区,欧美自拍网站一二,亚洲AV熟女传媒一区二区三区,亚洲在线麻豆

咨詢熱線

15000266580

當前位置:首頁  >  技術文章  >  日本批準利用干細胞療法治療眼部疾病

日本批準利用干細胞療法治療眼部疾病

更新時間:2013-07-26      點擊次數(shù):3591

   日本研究人員獲得批準,可以開展利用干細胞療法治療老年性黃斑變性(age-related macular degeneration,AMD),一種引起老年人視力下降的主要疾病。日本的研究人員誘導AMD患者身上取下的皮膚細胞使其處于一種類似于干細胞的狀態(tài)后再將其轉至患者,以達到治療效果。

干細胞具有廣泛的性,具有廣泛的醫(yī)療前景。去年,Kyoto University的Shinya Yamanaka即憑借干細胞領域的研究獲得諾貝爾獎。

詳細英文報道:

Japanese researchers have won permission to embark on a pioneering clinical study of a stem cell therapy for age-related macular degeneration, a major cause of vision loss in aging patients. The planned trial is being hailed as the first human test of a stem cell therapy made from patients' own cells.

Japan provides an appropriate proving ground for induced pluripotent stem (iPS) cell therapies. Last year professor Shinya Yamanaka of Kyoto University won a piece of a Nobel Prize for his work on converting adult cells into stem cells. The stem cells have broad potential in medicine because they can evolve into a variety to cell types with the potential to repair diseased or damaged organs, and they skirt the political quagmire of harvesting stem cells from human embryos.

As AFP reported, researchers in the Japanese study plan to take skin cells from AMD patients, coax the cells into a stem-like state, and then reintroduce them to the patients. The study calls for testing the therapeutic approach in 6 patients, with the trial set to begin next year in Kobe. Applications to conduct the trial came from the Riken Center for Developmental Biology and the Institute of Biomedical Research and Innovation.

Stem cells offer a whole new way to treat vision problems. Today, AMD patients take injected therapies such as Eylea and Lucentis to combat the disease by inhibiting VEGF to stymie the formation of leaky blood vessels, which lead to deterioration of the eye tissue that is key to central vision.

However, with pioneering clinical trials comes great risk. As professor Chris Mason of University College London noted to the BBC, researchers lack evidence on the safety of iPS cells in humans. The hope is that using patients' own cells to generate the therapies could reduce the risk of their bodies rejecting the stem cells.

 

聯(lián)系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區(qū)四平路710號7層

咨詢熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢
  • 掃一掃 微信咨詢

Copyright©2025 上海復祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
技術支持:化工儀器網    管理登陸
电白县| 小雪第一次交换又粗又大老杨| 美国一区二区三区无码视频| 国产精品三级a三级三级午夜| 久久综合爱| 精品| 国产成人精品一区二区色戒| 又大又粗又爽又黄的少妇毛片| 麻豆最新国产AV原创精品| 性色AV无码久久一区二区三区| 久久国产精品老女人| 小妖精又紧又湿高潮H视频69| 久久亚洲精品成人无码| 沈阳市| 天天躁日日躁狠狠躁性色av| 一本色道久久综合亚洲精品蜜桃冫| 伊人久久综合| 中文字幕人妻熟妇| 精品国产乱码久久久久久丨区2区 91麻豆精品91久久久久久清纯 | 妺妺窝人体色www在线| 国内精品久久久久久久影视| 高潮毛片无遮挡高清免费视频| 久亚洲一线产区二线产区三线产区| 成人一区二区三区视频在线观看 | 久久精品AⅤ无码中文字字幕不卡 国产成人精品日本亚洲专区61 | 鲁死你资源站亚洲av一级aⅴ| 国产亚洲女人久久久久毛片 | 欧美一级黄片免费看| 欧美一区2区三区4区贰佰公司| www.香蕉视频| 美丽的水蜜桃2| 日韩久久| 日视频| 国产av无遮挡| 日本网站| 青柠影院| 日日碰狠狠添天天爽| 无码 一区二区三区 水蜜桃| 亚洲AV无码一区二区三区网站| 免费男人和女人牲交视频全黄| 亚洲AV噜噜狠狠网址蜜桃|